Buffalo Sabres' Jiri Kulich on Track to Return Following Career-Threatening Blood Clot

The news that stops a professional hockey career in its tracks rarely happens during a collision on the ice. For Buffalo Sabres forward Jiri Kulich, the devastating blow came in the form of a blood clot diagnosis early in the 2025-26 season, a terrifying medical hurdle that immediately shifted the conversation from his top-six potential to his long-term health. Now, after months of quiet rehabilitation and uncertainty, the 22-year-old Czech standout has shared a decidedly positive update on his recovery, signaling that a return to the NHL is finally on the horizon.[2][6]

According to recent reports from NHL insider Elliotte Friedman, the Sabres organization initially harbored "serious concerns" about whether Kulich would ever be able to play professional hockey again. Blood clots are notoriously unpredictable, and for athletes in high-impact sports, the condition presents a unique set of dangers that go far beyond the initial vascular blockage.[1][7]

The primary danger lies in the treatment. Dissolving a blood clot requires the use of powerful blood thinners, medications that make the body highly susceptible to internal bleeding. In a sport defined by heavy body checks, slashing sticks, and 100-mile-per-hour slap shots, playing while on blood thinners is considered medically unviable. This reality has forced several notable players, including former Pittsburgh Penguins forward Pascal Dupuis, into early retirement.[3][6]

However, the narrative surrounding Kulich shifted dramatically this week. The young forward confirmed that his rehabilitation is firmly on the right track, indicating that his medical team is satisfied with his vascular response and that the worst of the scare is behind him. The update breathes new life into the Sabres' offseason, transforming a looming tragedy into a story of profound resilience.[2][5]

Kulich’s absence was deeply felt in Buffalo. Selected in the first round of the 2022 NHL Draft, he had just begun to cement his place as a cornerstone of the franchise's offensive future. During his first full NHL campaign in 2024-25, he tallied 15 goals and nine assists across 62 games, showcasing a lethal one-timer that quickly made him a fixture on the team's power-play unit.[3][7]

The 2025-26 season was widely projected to be his breakout year. Instead, he was limited to just 12 games before the medical staff discovered the clot and immediately shut him down. The sudden halt to his development was a severe blow to a Buffalo squad desperate for consistent goal-scoring, though the organization's primary concern remained strictly on the young forward's overall well-being.[1][6]

With Kulich now trending toward a return, the Sabres face the delicate task of managing his physical reintegration. Medical protocols for returning from blood clots are incredibly strict, requiring a careful tapering of medication and rigorous monitoring of the cardiovascular system's response under extreme physical duress.[3]

Buffalo's front office is expected to err heavily on the side of caution. Rather than thrusting him directly into the grueling 82-game NHL grind at the start of training camp, the team is reportedly considering a conditioning stint with their American Hockey League affiliate, the Rochester Americans.[4][7]

A brief tenure in Rochester would serve multiple purposes. It would allow Kulich to regain his timing, edge work, and game speed in a slightly lower-pressure environment after missing nearly a full calendar year of competitive action. Crucially, it also provides the medical staff with a controlled setting to evaluate his physical response to game-level contact before he re-enters the NHL spotlight.[4]

For the Sabres, getting a healthy Kulich back is akin to acquiring a premium asset in the free-agent market. His offensive toolkit—specifically his ability to find soft ice in the offensive zone and finish plays from the right circle—is a rare commodity. If he can safely resume his previous developmental trajectory, Buffalo regains a vital piece of their long-term rebuilding puzzle.[2][3]

Back in his native Czechia, the news of Kulich's recovery has been met with widespread relief and celebration. As one of the country's most promising young exports, his health scare resonated deeply within the European hockey community, which views him as a future fixture for their national team in upcoming international tournaments.[5]

Beyond the tactical implications for the Sabres, Kulich’s return offers a profound emotional lift for the entire locker room. In a sport that constantly demands physical toughness, overcoming a silent, internal threat like a blood clot requires a vastly different kind of endurance. As the summer progresses and training camp approaches, the hockey world will be watching closely, rooting for the young forward to take his rightful place back on the ice.[2][6]